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What’s Known on This Subject 
Injuries in children and young adults commonly cause morbidity and mortality. Epilepsy is 
common among children. There may be an increased risk of injury among those with 
epilepsy but there are few large, population-based studies making it difficult to estimate risk. 
 
What This Study Adds 
Children and young adults with epilepsy are at an increased risk of medicinal poisonings, 
thermal injuries and fractures compared to those without epilepsy. Young adults with 
epilepsy are at particularly high risk of medicinal poisonings.
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Structured Abstract 
Objective To investigate whether children and young adults with epilepsy are at an increased 
risk of fracture, thermal injury, or poisoning compared to those without. 
Patients and Methods A cohort study was conducted using the Clinical Practice Research 
Datalink (CPRD) (1987-2009), a longitudinal database containing primary care records. 
11,934 with epilepsy and 46,598 without, aged between 1-24 years at diagnosis were 
followed for a median (interquartile range) of 2.6 (0.8 to 5.9) years. The risk of: (i) fractures 
(including long bone fractures) (ii) thermal injuries, and (iii) poisonings (including medicinal 
and non-medicinal poisonings) was estimated. 
Results Adjusting for age, sex, Strategic Health Authority region, deprivation and calendar 
year at study entry (and, for medicinal poisonings, behavior disorder): people with epilepsy 
had an 18% increase in risk of fracture, (HR=1.18 (95% CI 1.09 to 1.27)); a 23% increase in 
risk of long bone fracture, (HR=1.23 (95% CI 1.10 to 1.38)); a 49% increase in risk of 
thermal injury (HR=1.49 (95% CI 1.27 to 1.75)) and more than double the risk of poisoning 
(HR=2.47 (95% CI 2.15 to 2.84), which was limited to poisoning from medicinal products 
(medicinal HR=2.54 (95% CI 2.16 to 2.99), non-medicinal HR=0.96 (95% CI=0.61 to 1.52)). 
Conclusions Children and young adults with epilepsy are at a greater risk of fracture, thermal 
injury and poisoning compared to those without. The greatest risk is from medicinal 
poisonings. Doctors and other healthcare professionals should provide injury and poison 
prevention advice at diagnosis and epilepsy reviews.
  
Introduction 
Epilepsy is a chronic neurological condition causing unprovoked recurrent seizures due to 
excessive cerebral neurological activity1 2. It is common, affecting approximately 2 million 
adults and 468,000 children in the United States (US)2. Worldwide, injuries are a leading 
cause of morbidity and mortality in children.3 Unintentional injuries are an important public 
health problem in the US4, with an incidence of 2,000 medically attended injuries per 10,000 
person years5 and a total lifetime cost in under 25-year-olds of $130 billion in 20005. The 
epidemiology of injury varies by age6-9 and boys are more likely than girls to sustain injuries, 
especially as teenagers9-11. Fractures are common with incidence estimates ranging from 133 
to 201 per 10,000 person years in children12-14 to 254 per 10,000 person years in all ages5 for 
medically attended fractures. Thermal injuries are common in children and young adults15 16, 
with incidence in the US of 34 medically attended injuries per 10,000 person years in under 
25-year-olds, and a total lifetime cost of $440 million in 20005. Unintentional poisonings are 
a significant cause of deaths worldwide17 in children and young adults and were the third 
leading cause of injury hospitalizations in the US in 20005, with an incidence of 60 medically 
attended injuries per 10,000 person years in under 25-year-olds and  a total lifetime cost of 
$583 million5. 
Previous studies, mainly in adults, suggest epilepsy is associated with an increased risk of 
injuries,18 19 thought to be due to  the seizures themselves, and adverse effects of anti-
epileptic drugs (AED’s)20 21. Earlier studies on epilepsy and injuries may have overestimated 
injury risk by using populations with more severe epilepsy, such as institutionalised adults22, 
or those in epilepsy clinics18. Questionnaire-based studies ascertaining injury retrospectively 
are subject to recall bias, with caregivers or relatives more likely to recall an injury if the 
participant has epilepsy19. Few studies have measured the rate of injuries prospectively in the 
general population23-25. A prospective European study in over 5-year-olds found no increased 
  
injury risk associated with epilepsy25, whilst a US study concluded the risk of serious injuries 
in epilepsy is minor26 and a UK study using the Clinical Practice Research Datalink (CPRD) 
reported the risk of fracture in people with epilepsy to be double those without epilepsy27. 
None of these studies focused on children and young adults with epilepsy; hence there is a 
lack of data for informing people with epilepsy about injury risk. We therefore investigated 
whether children and young adults with epilepsy are at an increased risk of fracture, thermal 
injury, or poisoning compared to people without epilepsy and estimated the risk of injury up 
to five years after diagnosis with epilepsy.
  
Methods 
Study population 
We conducted a cohort study using medical records of children and young adults from the 
Clinical Practice Research Datalink (CPRD); a primary care database containing medical 
records of approximately 12 million people (66 million person years of follow-up) from 625 
General Practitioner (GP) (family doctor) practices, and representing 8% of the UK 
population28. The CPRD is subjected to rigorous data quality checks (e.g. ensuring that a 
minimum of 95% of patient encounter events are recorded, validation checks and audits29) 
and a recent systematic review30 demonstrated the high validity of a range of diagnoses in the 
CPRD, with a median of 89% of cases confirmed by GP record request, algorithm and 
manual review30. The CPRD contains information on consultations with the GP, hospital 
attendances and admissions coded using Read codes31 as well as information on 
prescriptions. Read codes use a system similar to the systematized nomenclature of medicine 
(SNOMED) or International Classification of Disease (ICD) systems for use in UK primary 
care31. Lists of Read and drug codes for epilepsy were drawn up by two researchers. CPRD 
extracted records of people with a code for epilepsy or anti-epilepsy drug (AED) recorded 
whilst registered in the database before the age of 25 years from 1st January 1987 up to 31st 
December 2009. People with epilepsy were frequency-matched by practice and five-year age 
band to up to five people who did not have epilepsy. The lists of Read code descriptions and 
drug codes used are available from the authors on request. 
We took the date of the first Read code or AED prescription to be the date of diagnosis with 
epilepsy. We randomly assigned a date of ‘pseudodiagnosis’ for those without epilepsy that 
could be on any date starting from three months after they registered with the practice and up 
to the date they left the practice using a computer algorithm. Age was described in terms of 
the age of individuals at (pseudo)diagnosis.  
  
Definition of epilepsy 
Epilepsy was defined as having at least two Read codes for epilepsy or at least two AED 
prescriptions. To ensure that people with epilepsy included those with an incident diagnosis, 
made after they joined the current GP practice, we explored the time between the date of 
registration with the GP and diagnosis of epilepsy for each age group based on work that 
showed that, in people of all ages, the time taken for incidence rates of chronic conditions to 
reach a plateau post-registration can vary from 4-12 months, depending on ages and the 
condition32. Our work suggested that incident diagnoses were those made later than three 
months from registering with the GP for children 14 years old or less and later than 6 months 
post registration for people over 15 years old. People with prevalent epilepsy or with only one 
epilepsy Read code or AED prescription were excluded from the analyses. 
Definition of outcome and follow-up 
The outcome was the first injury to occur after (pseudo)diagnosis of epilepsy. Each injury 
type (fractures, thermal injuries and poisonings) was chosen a priori and identified using a 
list of Read codes (descriptions available on request). We included both mechanisms of 
injury (e.g. accidents caused by fire and flames) and anatomic sites of injury (e.g. burn of 
lower limbs) to maximise ascertainment of injuries. We followed people from the date of 
diagnosis of epilepsy (or the pseudodiagnosis date for those without epilepsy) to the earliest 
of the date of the first injury code, of leaving the CPRD (e.g. transfer to a new practice), or 
31st December 2009. People who had a record of the injury before the date of 
(pseudo)diagnosis were excluded from the analysis of that injury type because people with a 
previous injury have a higher risk of a subsequent injury33 34. We also explored the 
relationship between epilepsy and long bone fractures (as indicators of severe injury35 36), and 
between epilepsy and medicinal and non-medicinal poisonings separately (as those with 
epilepsy may have greater access to medicines than those without).  
  
Confounders 
Estimates were adjusted for age, sex, Strategic Health Authority (SHA) region of the practice, 
socioeconomic status and calendar year at study entry. We used the Index of Multiple 
Deprivation (IMD) of the GP practice as a proxy measure of the person’s socioeconomic 
status. IMD scores were categorised into national (England, Scotland, Wales and Northern 
Ireland) quintiles. Using Read codes, we identified several comorbid conditions that may 
confound the relationship between epilepsy and injury. These included attention-deficit 
hyperactivity disorder (ADHD); behavior disorder (including oppositional defiant disorder, 
antisocial behavior and behavior disorder), learning disability and cerebral palsy.  
Statistical analysis 
We described categorical variables using frequencies and proportions. The age bands chosen 
were: 1;2;3;4;5-9;10-14;15-18; and 19-24 years for analyses on fractures but in the analyses 
on thermal injuries and poisonings under 5’s were grouped together due to small numbers of 
events. We estimated crude rates for the first type of each injury after diagnosis for people 
with and without epilepsy, with 95% confidence intervals (95% CI). We estimated hazard 
ratios (HRs) for people with epilepsy compared to those without, using a Cox regression 
model. We adjusted hazard ratios for confounders (age, sex, SHA region, practice level 
deprivation and calendar year at study entry). We then adjusted for each comorbid condition 
(ADHD, behavior disorder, learning disability, cerebral palsy) in turn. When adjustment for a 
comorbid condition led to a change of >10% in the adjusted HR the confounder was retained 
in the model and the remaining comorbid conditions were assessed for inclusion in the model 
as described. 
We explored interactions by age and sex by adding interaction terms to the models with a 
p<0.05 taken as statistically significant. Models were checked by inspection of plots of the 
  
logarithm of cumulative hazard against time, Schoenfeld residuals against time and a 
statistical test for non-proportional hazards for people with epilepsy compared to those 
without in the final model. The number of people out of a thousand who had an injury within 
five years of diagnosis was estimated for each injury type. We undertook sensitivity analyses 
assessing the robustness of our findings in terms of our definition of epilepsy. Firstly, we 
used a stricter definition of epilepsy as: people with at least two AED prescriptions and two 
diagnosis codes, secondly we excluded those with a first AED of either pregabalin or 
gabapentin because these drugs can be prescribed for other diagnoses, and thirdly, we 
excluded those with AED prescriptions but no Read code for diagnosis of epilepsy. We also 
recalculated the risk of injuries in those aged 1-21 years to assess whether the estimates of 
risk differed when young adults above 21 years were excluded from the population. Lastly, as 
virtually all those with long-bone fractures would have attended secondary care, we assessed 
completeness of ascertainment of long-bone fracture risk in the practice records using around 
half the sample who had linked hospital records from the Hospital Episodes Statistics (HES) 
database. HES data include diagnosis codes, using the International Classification of Diseases 
(ICD) version 1037, and procedure codes, using the Office of Population Censuses and 
Surveys (OPCS-4) version 438 from inpatient admissions to hospital in England. All long 
bone fracture codes recorded during study follow-up in the hospital records were identified. 
People who had a long bone fracture recorded in hospital but not by the GP were then 
reclassified as having a long bone fracture in a separate analysis of the risk of long bone 
fractures. Statistical analysis was performed using Stata version 12MP (Stata Corp. College 
Station, TX).  
Ethics 
  
Approval was obtained from the CPRD’s own independent scientific advisory committee, 
ISAC. CPRD data are anonymized and further ethics approval was not required. 
  
Results 
Table 1 shows participant characteristics. In the analysis of fractures, there were 10,447 
eligible people with epilepsy and 42,181 without. In total, there were 231,478 person years of 
follow-up. The characteristics of those included in the analyses for thermal injuries and 
poisonings were similar to those included in the analyses for fractures. 
Table 2 shows risk of injury in people with epilepsy compared to those without. The highest 
rate of injuries was for any fractures (16.8 (95% CI 15.8 to 17.9) per 1000 person years in 
epilepsy vs. 14.4 (95% CI 13.8 to 15.0) per 1000 person years in those without), followed by 
any poisoning (6.2 (95% CI 5.6 to 6.8) vs. 2.5 (95% CI 2.3 to 2.8) per 1000 person years), 
and thermal injuries (3.8 (95% CI 3.3 to 4.3) vs. 2.5 (95% CI 2.3 to 2.8) per 1000 person 
years). After adjusting for age, sex, SHA region, practice-level deprivation and calendar year 
at study entry, people with epilepsy had a more than doubling of risk of poisoning compared 
to those without (adjusted HR=2.47 (95% CI 2.15 to 2.84)), a 1.5 fold increase in the risk of 
thermal injury (adjusted HR=1.49 (95% CI 1.27 to 1.75) and an 18% increase in risk of 
fracture (adjusted HR=1.18(1.09 to 1.27)). Restricting analyses to long bone fractures had 
little effect on hazard ratio estimates (adjusted HR=1.23 (95% CI 1.10 to 1.38)). The HR for 
medicinal poisonings was reduced after further adjusting for behavior disorder (HR=2.54 
(95% CI 2.16 to 2.99)) but adjustments for this and for other co-morbidities made little 
difference to the other HR estimates. Analysing by poisoning agent revealed that the 
increased risk of poisoning in people with epilepsy reflected medicinal poisonings (HR=2.54 
(95% CI 2.16 to 2.99)) rather than poisonings by non-medicinal products (HR=0.96 (95% CI 
0.61 to 1.52)).  
We explored whether the increased risk of injury in people with epilepsy varied by age and 
sex. There was some evidence of an interaction with sex for medicinal poisonings (test for 
  
interaction p=0.04), with a greater HR for males compared to females (adjusted HR=3.11 
(95% CI 2.41 to 4.01) vs. 2.23 (95% CI 1.81 to 2.74), adjusting for age, SHA region, practice 
level deprivation, calendar year at study entry and behavior disorder). There was no evidence 
for an interaction with sex for other injury types. There was strong evidence to suggest the 
relative risk of poisoning varied by age (test for interaction p<0.001), with the greatest 
increased risk in the 19 to 24-year-olds (adjusted HR=3.94 (95% CI 2.94 to 5.27)) and least 
in the 10 to 14-year-olds (adjusted HR=1.52 (95% CI 1.15 to 2.01)), adjusting for age, sex, 
SHA region, practice level deprivation and calendar year at study entry. After restricting 
analyses to medicinal poisonings (Figure 1), these age-specific patterns of increased risk 
persisted  (test for interaction p=0.01;  adjusted HR for 19-24 year-olds=3.59 (95% CI 2.65 to 
4.86); adjusted HR in 10-14-year-olds=1.71 (95% CI 1.23 to 2.37), adjusting for, sex, SHA 
region, practice level deprivation, calendar year at study entry and behavior disorder). The 
drug involved in the poisoning incident was only recorded in 5% of medicinal poisonings in 
people with epilepsy and 5% of those without epilepsy. 2% of all medicinal poisonings in 
people with epilepsy were due to an AED. 
Absolute risks of injury in the five year period following (pseudo)diagnosis in people with 
and without epilepsy are shown in Table 3. Per thousand people, those with epilepsy 
experienced an extra 23 poisonings (21 of which were medicinal poisonings), an extra 12 
fractures (two of which were long bone fractures) and an extra seven thermal injuries. 
Our findings were robust to restricting analyses to people with at least two drug prescriptions 
and two diagnosis codes for epilepsy, to excluding those prescribed pregabalin or gabapentin 
as their first anti-epilepsy drug and to excluding 3,554 people with AED prescriptions but no 
Read code for a diagnosis of epilepsy. Results for people aged 1-21 years were very similar 
to those for people aged 1-24 years (fractures 1.15 (95% CI 1.06 to 1.25); thermal injuries 
  
1.39 (95% CI 1.18 to 1.65); poisonings 2.26 (95% CI 1.95 to 2.62); long bone fractures 1.20 
(95% CI 1.06 to 1.35); medicinal poisonings 2.39 (95% CI 2.01 to 2.84); non-medicinal 
poisonings 0.89 (95% CI 0.56 to 1.42)). 25,723 people had hospital records linked to their GP 
record. The risk of long bone fractures for this sub-group was similar to the whole population 
(adjusted HR=1.25 (95% CI 1.07 to 1.46)).
  
Discussion 
Children and young adults with epilepsy are at greater risk of fractures, thermal injuries and 
poisonings compared to those without epilepsy. In people with epilepsy fractures are 18% 
more likely, thermal injuries 50% more likely and poisonings more than twice as likely 
compared to people without epilepsy, with the increased risk being restricted to medicinal 
poisonings. Among young adults with epilepsy, aged 19 to 24 years, the risk of medicinal 
poisoning was four-fold that of the general population of the same age. The absolute risk of 
injury in the five year period following diagnosis was an additional: 12 fractures (2 long 
bone); 7 thermal injuries and 23 poisonings (21 medicinal poisonings). Those with epilepsy 
aged between 19 to 24 years were at the greatest risk of poisonings compared to those 
without epilepsy. 
To our knowledge, this is the first study to explore associations between epilepsy and 
fractures, thermal injuries and poisonings in children and young adults in the primary care 
population. As the primary care record contains information on diagnoses made in both 
secondary and primary care this provides a more complete picture of the risk of fractures, 
thermal injuries and poisonings than previous studies. Misdiagnosis of epilepsy is unlikely as 
childhood epilepsy is diagnosed by specialists in secondary care with on-going prescriptions 
provided in primary care39 40. Misclassification of epilepsy could have occurred but our 
sensitivity analyses using stricter criteria to define epilepsy made little difference to the 
estimated risks of injuries, suggesting any misclassification is likely to have minimal impact 
on our findings. Misclassification of the injuries could have occurred if an injury was not 
coded by the GP or an injury that had not occurred was incorrectly coded as occurring. 
However, we found similar hazard ratios for all fractures and for long bone fractures, which 
we expected to have high levels of recording41. For a sub-group including long bone fractures 
recorded in hospital records we found a similar estimated risk. We included both mechanisms 
  
of injury (e.g. accidents caused by fire and flames) and anatomic sites of injury (e.g. burn of 
lower limbs) to maximise ascertainment of injuries. There is a potential risk of ascertainment 
bias, whereby people with epilepsy who may have higher GP consultation rates have more 
opportunities to report injuries than people without epilepsy. Our findings of similar hazard 
ratios for all fractures and for long bone fractures would suggest this was not occurring to a 
large degree. We have no reason to suspect that misclassification for poisonings or thermal 
injuries would be greater than that for fractures and any possible misclassification would tend 
the hazard ratio towards unity, meaning our estimates were conservative estimates of injury 
risk. Whilst we adjusted for key confounders, it is possible that some residual confounding 
remains. We were unable to explore the contribution of anti-epileptic drugs to the increased 
risk of poisoning because the drug involved was not recorded in most cases of poisoning. 
Although any comparison of rates of all injury types in our study with those of previous work 
are limited, due to the lack of population-based studies in comparable age groups, the rates of 
fractures in people without epilepsy are broadly comparable to those from previous studies12-
14 42 but lower than those in one CPRD study in all ages which estimated an age- and sex-
adjusted incidence rate ratio for fractures among epilepsy patients compared to those without 
of 1.89 (95% CI 1.81 to 1.98)27. The greater fracture risk in that study may be, at least partly, 
explained by the severity of epilepsy as the study population comprised those with active 
epilepsy, with drugs or diagnosis codes recorded for more than one year. There are no 
previous studies reporting the risk of thermal injuries or poisonings in people with epilepsy to 
those without in the general population, therefore comparison of our findings with previous 
studies is not possible. 
Potential explanations for increased risk of injuries associated with epilepsy include injuries 
occurring as a result of seizures (e.g. fractures43 44 and thermal injuries45-48). Epilepsy itself 
  
may be associated with pathology of the central nervous system that increases injury risk and 
in the case of poisonings an increased access to medicines (for unintentional poisoning or for 
self-harm with any medication49) or inadvertent overdosage of AED. We found 19 to 24-
year-olds with epilepsy had the highest risk of poisonings, with potential explanations 
including self-harm or greater risk-taking behavior. Previous work suggests people with 
epilepsy may have a greater risk of suicide than those without epilepsy50. It is therefore 
possible that some of the observed increased risk of poisoning was intentional as opposed to 
unintentional poisoning. Although we were unable to explore associations between poisoning 
with specific drugs and epilepsy, it is possible that easy access to anti-epileptic drugs may be 
important in this context. Whilst this study does not allow us to explore the reasons why 
injury risks are increased in people with epilepsy, it allows quantification of  risk and 
highlights that the absolute risk of poisoning is substantially greater than that for fractures or 
for burns.  
Conclusion 
All healthcare professionals can use these findings to inform parents, children and young 
adults diagnosed with epilepsy of their absolute risk of injuries as part of counselling for 
unintentional injury prevention51 and to inform  existing guidelines on treatment52. For 
fractures and thermal injuries, the increase in absolute risk associated with epilepsy is small. 
Given the increased risk of poisoning, in particular among young adults, efforts should be 
made to prevent this injury. For example, information could be provided on the risk of 
medicinal poisoning and advice about safe storage of all medicines (not just anti-epileptic 
drugs), not transferring medicines to other containers, supervising children taking medicine 
and about the dangers of overdosing53-55. This information could be provided when 
prescribing medication and during epilepsy reviews and pharmacists can also provide such 
  
information when dispensing antiepileptic drugs to children and young adults. More research 
is needed to distinguish intentional from unintentional poisonings, especially in older children 
and young adults so that the increased risk of poisoning, by intent, can be described in 
children and young adults with epilepsy. Further research exploring the contribution of anti-
epileptic drugs to poisonings in children with epilepsy would also be helpful to enable more 
specific prevention advice to be provided to parents, children and young adults.
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Table 1 Characteristics of people with epilepsy and those without for analyses of fractures, thermal injuries and poisonings
Study cohort
Characteristic Non-epilepsy Epilepsy Non-epilepsy Epilepsy Non-epilepsy Epilepsy
n=42,181 n=10,447 n=46,598 n=11,934 n=46,576 n=11,720
Age group at 1 1,751 (4.2) 535 (5.1) 1,751 (3.8) 535 (4.5) 1,754 (3.8) 540 (4.6)
(pseudo)diagnosis 2 1,623 (3.9) 459 (4.4) 1,623 (3.5) 457 (3.8) 1,643 (3.5) 460 (3.9)
of epilepsy (years) 3 1,589 (3.8) 485 (4.6) 1,605 (3.4) 489 (4.1) 1,610 (3.5) 494 (4.2)
(n, %) 4 1,764 (4.2) 448 (4.3) 1,759 (3.8) 489 (4.1) 1,787 (3.8) 448 (3.8)
5-9 8,598 (20.4) 2,115 (20.3) 8,950 (19.2) 2,223 (18.6) 9,021 (19.4) 2,247 (19.2)
10-14 8,983 (21.3) 2,009 (19.2) 10,059 (21.6) 2,284 (19.1) 10,109 (21.7) 2,311 (19.7)
15-18 6,826 (16.2) 1,792 (17.2) 7,909 (17.0) 2,183 (18.3) 7,889 (16.9) 2,135 (18.2)
19-24 11,047 (26.2) 2,604 (24.9) 12,942 (27.8) 3,317 (27.8) 12,763 (27.4) 3,085 (26.3)
Sex (n, %) Males 19,953 (47.3) 5,291 (50.7) 22,598 (48.5) 6,185 (51.8) 22,705 (48.8) 6,152 (52.5)
SHA East Midlands 2,422 (5.7) 542 (5.2) 2,422 (5.7) 542 (5.2) 5,957 (12.8) 1,523 (13.0)
region (n, %) East of England 4,457 (10.6) 1,111 (10.6) 4,457 (10.6) 1,111 (10.6) 4,548 (9.8) 1,105 (9.4)
London 4,288 (10.2) 1,013 (9.7) 4,530 (9.7) 1,119 (9.4) 3,483 (7.5) 976 (8.3)
North East 1,118 (2.7) 288 (2.8) 1,118 (2.7) 288 (2.8) 3,878 (8.3) 1,005 (8.6)
North West 5,386 (12.8) 1,341 (12.8) 5,963 (12.8) 1,549 (13.0) 4,190 (9.0) 933 (8.0)
Northern Ireland 1,219 (2.9) 369 (3.5) 1,219 (2.9) 369 (3.5) 4,569 (9.8) 1,184 (10.1)
Scotland 3,036 (7.2) 828 (7.9) 3,484 (7.5) 1,003 (8.4) 3,959 (8.5) 994 (8.5)
South Central 3,586 (8.5) 877 (8.4) 3,586 (8.5) 877 (8.4) 4,893 (10.5) 1,198 (10.2)
South East Coast 3,542 (8.4) 891 (7.9) 3,875 (8.3) 1,033 (8.7) 3,439 (7.4) 927 (7.9)
South West 3,792 (9.0) 854 (8.2) 4,196 (9.0) 944 (7.9) 2,371 (5.1) 557 (4.8)
Wales 3,076 (7.3) 791 (7.6) 3,457 (7.4) 938 (7.9) 2,686 (5.8) 587 (5.0)
West Midlands 4,138 (9.8) 1,047 (10.0) 4,563 (9.8) 1,198 (10.0) 1,380 (3.0) 417 (3.6)
Yorkshire & Humber 2,121 (5.0) 495 (4.7) 2,371 (5.1) 556 (4.7) 1,223 (2.6) 314 (2.7)
Deprivation (n, %) Least deprived 6,674 (15.8) 1,692 (16.2) 7,437 (16.0) 1,945 (16.3) 7,414 (15.9) 1,911 (16.3)
2nd least deprived 7,443 (17.7) 1,713 (16.4) 8,273 (17.8) 1,966 (16.5) 8,307 (17.8) 1,938 (16.5)
Medium deprivation 8,160 (19.4) 2,018 (19.3) 8,993 (19.3) 2,290 (19.2) 9,000 (19.3) 2,257 (19.3)
2nd most deprived 9,307 (22.1) 2,327 (22.3) 10,266 (22.0) 2,632 (22.1) 10,246 (22.0) 2,587 (22.1)
Most deprived 10,593 (25.1) 2,695 (25.8) 11,624 (25.0) 3,099 (26.0) 11,604 (24.9) 3,025 (25.8)
Calendar year at 1987-1989 230 (0.6) 44 (0.4) 237 (0.5) 47 (0.4) 237 (0.5) 47 (0.4)
study entry 1990-1994 4,804 (11.4) 1,122 (10.7) 5,048 (10.8) 1,217 (10.2) 5,042 (10.8) 1,211 (10.3)
1995-1999 7,228 (17.1) 1,925 (18.4) 7,786 (16.7) 2,112 (17.7) 7,806 (16.8) 2,097 (17.9)
2000-2004 12,271 (29.1) 3,382 (32.4) 13,455 (28.9) 3,850 (32.3) 13,487 (29.0) 3,786 (32.3)
2005 onwards 17,648 (41.8) 3,974 (38.0) 20,072 (43.1) 4,708 (38.5) 20,004 (43.0) 4,579 (39.1)
1,550 (3.7) 1,303 (12.5) 1,817 (3.9) 1,507 (12.6) 1,770 (3.8) 1,443 (12.3)
Learning disability 318 (0.8) 961 (9.2) 372 (0.8) 1,038 (8.7) 368 (0.8) 1,029 (8.8)
ADHD 374 (0.9) 363 (3.5) 426 (0.9) 426 (3.6) 428 (0.9) 421 (3.6)
Cerebral palsy 13 (<0.1) 29 (0.3) 14 (<0.1) 31 (0.3) 14 (<0.1) 30 (0.3)
Fractures Thermal injuries Poisonings
Behavior disorder
Note: Each study population comprises those without a history of the injury of interest
Note: Deprivation is at practice level  
  
Injury Epilepsy or Events pyar Rate HR (95% CI)
category non-epilepsy (n) (per 1000)
Any Non-epilepsy 2066 143,336 14.4 (13.8 -15.0) 1 1
fractures Epilepsy 948 56,310 16.8 (15.8 -17.9) 1.15 (1.07 -1.24) 1.18 (1.09 -1.27)
Thermal Non-epilepsy 415 164,247 2.5 (2.3 -2.8) 1 1
injuries Epilepsy 253 67,231 3.8 (3.3 -4.3) 1.51 (1.29 -1.77) 1.49 (1.27 -1.75)
Any poisonings Non-epilepsy 417 165,376 2.5 (2.3 -2.8) 1 1
Epilepsy 408 66,021 6.2 (5.6 -6.8) 2.57 (2.24 -2.95) 2.47 (2.15 -2.84)
Injury sub-groups:
Long bone Non-epilepsy 931 155,637 6.0 (5.6 -6.4) 1 1
fractures Epilepsy 438 63,454 6.9 (6.3 -7.6) 1.17 (1.04 -1.31) 1.23 (1.10 -1.38)
Medicinal Non-epilepsy 293 164,946 1.8 (1.6 -2.0) 1 1
poisonings Epilepsy 341 65,786 5.2 (4.7 -5.8) 3.06 (2.62 -3.59) 2.54 b (2.16 -2.99)
Non-medicinal Non-epilepsy 72 164,121 0.4 (1.9 -0.6) 1 1
poisonings Epilepsy 26 64,760 0.4 (1.9 -0.6) 0.92 (0.59 -1.45) 0.96 (0.61 -1.52)
pyar: Person years at risk (in years)
HR: Hazard ratio
aAll HRs were adjusted for for age, sex, SHA region, deprivation and calendar year at study entry except b
bHR additionally djusted for behaviour disorder
HRa
(95% CI) (95% CI)
Table 2 Risk of fractures, thermal injuries and poisonings in children & young adults with epilepsy compared to those without
Adjusted
  
Figure 1 Graphs to show risk of medicinal poisonings in people with epilepsy compared to 
those without by age at (pseudo)diagnosis. Graphs show the proportion who have a medicinal 
poisoning by time since (pseudo)diagnosis. Frequencies of people in study by year since 
(pseudo)diagnosis are shown for people with epilepsy and those without. 
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B. Age 5 to 9 years 
0
.0
0
0
.0
1
0
.0
2
0
.0
3
0
.0
4
0
.0
5
P
ro
p
o
rt
io
n
 o
f 
p
e
o
p
le
 w
h
o
 h
a
v
e
 a
 m
e
d
ic
in
a
l 
p
o
is
o
n
in
g
2237 2063 1851 1658 1444 1281Epilepsy
8992 6855 5671 4858 4164 3528Without epilepsy
Number at risk
0 1 2 3 4 5
Years since (pseudo)diagnosis
Without epilepsy Epilepsy
Risk of medicinal poisonings in people with epilepsy compared to those without
 
C. Age 10 to 14 years 
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D. Age 15 to 18 years 
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E. Age 19 to 24 years 
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Time since Total at risk Events Injuries Total at risk Events Injuries Excess injuries
diagnosis (n) (n) per thousand (n) (n) per thousand per thousand
Any fractures
Up to 5 years 10,605 976 69.5 (65.7 -73.4) 4,520 427 81.1 (74.6 -88.1) 11.6 (8.9 -14.7)
Thermal injuries
Up to 5 years 12,303 189 12.3 (10.9 -13.9) 5,416 115 19.2 (16.5 -22.4) 6.9 (5.6 -8.5)
Any poisonings
Up to 5 years 12,411 194 11.9 (10.6 -13.5) 5,310 186 34.7 (30.9 -38.9) 22.8 (20.3 -25.4)
Long bone fracture
Up to 5 years 11,592 479 31.5 (1.3 -34.1) 5,099 200 33.9 (2.1 -38.3) 2.4 (0.8 -4.2)
Medicinal poisonings
Up to 5 years 12,377 136 8.2 (7.1 -9.5) 5,293 157 29.3 (25.8 -33.2) 21.1 (18.7 -23.7)
Non-medicinal poisonings
Up to 5 years 12,312 34 2.1 (1.6 -2.9) 5,220 10 2.0 (1.2 -3.2) -0.1 (-0.4 -0.3)
(95% CI)
Injury sub-groups:
Table 3 Absolute risks of injury in the five year period following (pseudo)diagnosis in people with epilepsy and without epilepsy
Non-epilepsy Epilepsy
(95% CI) (95% CI)
 
